DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Emerging Electronic Tools in Cardiovascular Outcomes Studies

Session Chair(s)

Jonathan  Plehn, DrMed, FACC

Jonathan Plehn, DrMed, FACC

Vice President, Global Therapeutic Lead, Cardiovascular/Metabolic Unit

Covance Inc., United States

The costs of performing large cardiovascular outcomes trials is prohibitive and constraining to development of new molecular entities. We will describe novel electronic techniques that can add to trial rigor and efficiency while reducing costs.

Learning Objective : Identify challenges specific to large outcomes trials that can be addressed with novel electronic, web-based approaches; Describe the operation of electronic systems that add efficiency and reduce costs in large outcomes trials.

Speaker(s)

Steffan  Ekman, MPHARM, MSC, RPH

CV Endpoint Management: From Identification to Adjudication

Steffan Ekman, MPHARM, MSC, RPH

F. Hoffmann-La Roche AG , Switzerland

Senior Clinical Scientist

Judith  Teall, RN

Mobile Patient Engagement in Cardiovascular Outcomes: A Two Way Process

Judith Teall, RN

Independent Consultant, United Kingdom

Rob  Saiter, MS

Applications and Efficiencies of Research Portals in Cardiovascular Outcomes Trials

Rob Saiter, MS

Accenture, United States

Managing Director, Life Sciences R&D

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。